Variant report
Variant | nsv1001481 |
---|---|
Chromosome Location | chr2:209602873-209642036 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs138061991 | chr2:209621636-209621637 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs73070235 | chr2:209621641-209621642 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs148934626 | chr2:209621648-209621649 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs571535678 | chr2:209621654-209621655 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs185353629 | chr2:209621662-209621663 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs201733632 | chr2:209621676-209621677 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs189469322 | chr2:209621681-209621682 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs567398844 | chr2:209621697-209621698 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs181391389 | chr2:209621702-209621703 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs553128567 | chr2:209621723-209621724 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs566542794 | chr2:209621738-209621739 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs116749977 | chr2:209621769-209621770 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs542013207 | chr2:209621804-209621805 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs143636935 | chr2:209621823-209621824 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs76917428 | chr2:209621834-209621835 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs544625259 | chr2:209621846-209621847 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs555234112 | chr2:209621849-209621850 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs138353894 | chr2:209621850-209621851 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs373967582 | chr2:209621902-209621903 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs540405084 | chr2:209621905-209621906 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs530944839 | chr2:209621930-209621931 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs560236037 | chr2:209621961-209621962 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs532437180 | chr2:209621971-209621972 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs185793044 | chr2:209622007-209622008 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs142834804 | chr2:209622026-209622027 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs531731216 | chr2:209622042-209622043 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs73070237 | chr2:209622063-209622064 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs567528112 | chr2:209622082-209622083 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs529933151 | chr2:209622097-209622098 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs73070239 | chr2:209622100-209622101 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs551046583 | chr2:209622101-209622102 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs546299402 | chr2:209622107-209622108 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs538689553 | chr2:209622171-209622172 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs558616929 | chr2:209622202-209622203 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs1356379 | chr2:209622211-209622212 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
36 | rs537833446 | chr2:209622222-209622223 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs146136467 | chr2:209622231-209622232 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs1356378 | chr2:209622265-209622266 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
39 | rs540443800 | chr2:209622295-209622296 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs188314261 | chr2:209622334-209622335 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs138956311 | chr2:209622353-209622354 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs566572024 | chr2:209622357-209622358 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs546031344 | chr2:209622372-209622373 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs562993021 | chr2:209622379-209622380 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs141497822 | chr2:209622409-209622410 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs542176404 | chr2:209622442-209622443 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs535627229 | chr2:209622459-209622460 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs142688001 | chr2:209622478-209622479 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs561181048 | chr2:209622514-209622515 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs370939024 | chr2:209622529-209622530 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cervical cancer | 21062161 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Autism | 20808228 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Ovarian cancer | 19193619 | CNVD |
Non-small cell lung cancer | 18676828 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Chordoma | 18071362 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 18923514 | CNVD |
Schizophrenia | 22241247 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Developmental delay | 21147756 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:209621600-209622800 | Enhancers | Fetal Heart | heart |